Park, Keun-Ho
(Cardiovascular Center, Chonnam National University Hospital)
Ahn, Young-Keun (Cardiovascular Center, Chonnam National University Hospital) Jeong, Myung-Ho (Cardiovascular Center, Chonnam National University Hospital) Chae, Shung-Chull (Cardiovascular Center, Chonnam National University Hospital) Hur, Seung-Ho (Cardiovascular Center, Chonnam National University Hospital) Kim, Young-Jo (Cardiovascular Center, Chonnam National University Hospital) Seong, In-Whan (Cardiovascular Center, Chonnam National University Hospital) Chae, Jei-Keon (Cardiovascular Center, Chonnam National University Hospital) Hong, Taek-Jong (Cardiovascular Center, Chonnam National University Hospital) Cho, Myeong-Chan (Cardiovascular Center, Chonnam National University Hospital) Bae, Jang-Ho (Cardiovascular Center, Chonnam National University Hospital) Rha, Seung-Woon (Cardiovascular Center, Chonnam National University Hospital) Jang, Yang-Soo (Cardiovascular Center, Chonnam National University Hospital) Korean Acute Myocardial Infarction Registry Investigators, Korean Acute Myocardial Infarction Registry Investigators (Korean Acute Myocardial Infarction Registry Investigators) |
1 | Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:2035-2038. DOI ScienceOn |
2 | Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-989. DOI ScienceOn |
3 | Garg P, Normand SL, Silbaugh TS, et al. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry. Circulation 2008;118:2277-2285. DOI ScienceOn |
4 | Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234. DOI ScienceOn |
5 | Sprafka JM, Burke GL, Folsom AR, McGovern PG, Hahn LP. Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival: the Minnesota Heart Survey. Diabetes Care 1991;14:537-543. DOI ScienceOn |
6 | French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004;90:99-106. DOI ScienceOn |
7 | Mak KH, Moliterno DJ, Granger CB, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction: GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1997;30:171-179. DOI ScienceOn |
8 | Koek HL, Soedamah-Muthu SS, Kardaun JW, et al. Shortand long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus. Eur J Epidemiol 2007;22:883-888. DOI ScienceOn |
9 | Hirakawa Y, Masuda Y, Kuzuya M, Iguchi A, Kimata T, Uemura K. Influence of diabetes mellitus on in-hospital mortality in patients with acute myocardial infarction in Japan: a report from TAMIS-II. Diabetes Res Clin Pract 2007;75:59- 64. DOI ScienceOn |
10 | Kvan E, Pettersen KI, Sandvik L, Reikvam A; INPHARM Study Investigators. High mortality in diabetic patients with acute myocardial infarction: cardiovascular co-morbidities contribute most to the high risk. Int J Cardiol 2007;121:184-188. DOI ScienceOn |
11 | Norhammar A, Lindback J, Ryden L, Wallentin L, Stenestrand U; Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart 2007;93:1577-1583. |
12 | Hasin T, Hochadel M, Gitt AK, Behar S, Bueno H, Hasin Y. Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus. Am J Cardiol 2009;103:772-778. DOI ScienceOn |
13 | Hasdai D, Granger CB, Srivatsa SS, et al. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes. J Am Coll Cardiol 2000;35:1502-1512. DOI ScienceOn |
14 | Woodfield SL, Lundergan CF, Reiner JS, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1996;28:1661-1669. DOI ScienceOn |
15 | Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997;126:296-306. DOI ScienceOn |
16 | Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 2004;44:2293-2300. DOI ScienceOn |
17 | Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular ultrasound study. Circulation 1997;95:1366-1369. DOI ScienceOn |
18 | Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-670. DOI ScienceOn |
19 | Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003;108:1527-1532. DOI ScienceOn |
20 | Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998;32:1866-1873. DOI ScienceOn |
21 | Mehilli J, Kastrati A, Schuhlen H, et al. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation 2004;110:3627- 3635. DOI ScienceOn |
22 | Kalarus Z, Lenarczyk R, Kowalczyk J, et al. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am Heart J 2007;153:304-312. DOI ScienceOn |
23 | West NE, Ruygrok PN, Disco CM, et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation 2004;109:867-873. DOI ScienceOn |
24 | Radke PW, Voswinkel M, Reith M, et al. Relation of fasting insulin plasma levels to restenosis after elective coronary stent implantation in patients without diabetes mellitus. Am J Cardiol 2004;93:639-641. DOI ScienceOn |
25 | Takagi T, Akasaka T, Yamamuro A, et al. Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantation: intravascular ultrasound studies. J Diabetes Complications 2002;16:50-55. DOI ScienceOn |
26 | Piatti P, Di Mario C, Monti LD, et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 2003;108:2074-2081. DOI ScienceOn |
27 | Takara A, Ogawa H, Endoh Y, et al. Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization. Cardiovasc Diabetol 2010;9:1. DOI ScienceOn |
28 | Hong YJ, Jeong MH, Park OY, et al. The role of C-reactive protein on the long-term clinical outcome after primary or rescue percutaneous coronary intervention. Korean J Intern Med 2003;18:29-34. DOI |
![]() |